Status:
COMPLETED
Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease
Lead Sponsor:
Habibedurdu
Conditions:
Interstitial Lung Disease
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
65-85 years
Brief Summary
Interstitial lung disease (ILD) is a restrictive lung disease characterized by impaired lung function, exercise limitation and skeletal muscle dysfunction. There is limited data on skeletal muscle fun...
Detailed Description
This study consisted of intervention and control groups. Thirty one patients with ILD were included in the patient's group and 37 healthy volunteers in the control group. All participants were selecte...
Eligibility Criteria
Inclusion
- Diagnosed with ILD by a multidisciplinary team according to the 2011 ATS/ERS guidelines for ILD
- Aged 65-85
Exclusion
- Uncontrolled/active cardiovascular, metabolic, systemic or cancerous disease
- Significant orthopedic, neurologic or musculoskeletal comorbidity that limited functional independence
- No being able to cooperate
- Refuse to participate in the current study
Key Trial Info
Start Date :
January 23 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 23 2017
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04803617
Start Date
January 23 2017
End Date
June 23 2017
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Giresun University
Giresun, Turkey (Türkiye)